Documente Academic
Documente Profesional
Documente Cultură
Reverse Genetics:
Creation of a Mouse Model for a Human Disease via the
Transfection and Growth of Mouse Embryonic Stem Cells
Group 6:
Michael Jackson
Susan Liem
Introduction:
The field of genetics is one that is in a process of continual expansion as the
progression of biotechnology and laboratory innovation pushes the boundaries of once a
semi-static field into a multitude of arenas blurring the lines between different specialties
in biology. The methods utilized in these experiments are relatively routine today but
were novel in the 1980’s. The scientific approach that is exemplified in this five week
period is the process of reverse genetics. Reverse genetics is the process by which a gene
in mutated and the phenotypic consequence is then determined. This is a direct opposite
to the process of forward genetics in which a phenotypic mutation is observed and the
hunt is on to trace this mutation back to a target gene. The environment in which reverse
genetics was used in this class is in the field of mouse modeling of human disease
through the creation of homologous recombinant mouse cells to produce chimeric
(agouti) mice and then through selfing of progeny produce ¼ homozygous mutants in the
F2 generation. The production of ES cells that contained HRE is based of the past work
of many scientists and utilized many common techniques practices in labs around the
world.
Embryonic Stem Cell (ES cell) technology finds its roots in the early 1980’s when
the determination was made that ES cells are pluripotent, meaning that these ES cells can
become any cell line in the laboratory animal. The 1st isolation of ES cells came in 1981
Lab #2: Reverse Genetics
A02-92-6779
-2-
in the 3.5 day old embryo of a mouse (blastocysts). The stem cell is harvested from the
developing mouse embryos a short time after fertilization and before significant zygote
development into a viable embryo. The ES cells are maintained in culture via the use of
embryonic fibroblast cells (EF cells) which have been immortalized (halted in mitotic
development) to provide nutrients and growth factors to keep the ES cells from
differentiating. The first introduction of a germ line mutation in ES cells was in 1984.
The vector for introduction of the mutation was a retroviral vector. This vector was then
used to incorporate the mutation into a blastocyst and the production of an agouti mouse
was the result. This mouse was a chimeric mouse that when the progeny of the F1 were
selfed the F2 generation produces ¼ homozygous mutants which have two copies of the
mutant gene creating an organism that can become a model for human disease.
In 1987 the first gene targeting and knock out experiment was carried out in
which the procedure produced a method by which a normal gene could be replace with a
gene of interest using the DNA repair machinery of the host cell. The creation of this
knockout technique now allows for the ability to create mouse models of human disease
with a higher degree of efficiency. The knockout technique once perfected led to the
creation of skid mice (severe immune compromised) which are models for the human
immunodeficiency virus (HIV). The technique used in these labs to create a mouse
model for a human disease is transfection by electroporation of a linear targeting
construct.
The goal of these labs is to produce mouse models of human disease. This
process is made possible by advances in cellular manipulation and culture since 1980 that
have paved the way for the techniques of today. The major issue surrounding the
procedures and techniques used in this educational lab are the irregular sequence of
events that are not in sync with the actual progression in a diagnostic lab environment.
However, the techniques learned in this lab are the current and frequently used techniques
that will give the students of this class the ability to compete in a genetic biology lab and
provide the background to understand the process of gene targeting.
Table of Reagents:
c. Results:
i. MEF cells prepared and irradiated according to protocol. Sterile
technique followed and no contamination observed in the EF cells.
The immortalized cells will be used with ES cells as a feeder layer.
c. Results:
i. The EF 96 well flat bottom plate is created through this procedure
and it will be used to hold the colonies that survived the G418
selection after the transfection.
ii. The plate will be incubated until it is used with EF media on top of
the cells to prepare the feeder layer for the ES cells.
iii. The plate rows utilized by group 6 are as follows:
1. Susan Liem Row A 1-12 / B 1-12
2. Michael Jackson Row C 1-12 / D 1-12
iv. These selected 48 wells will be used to house 48 monoclonal
colonies of ES cells.
v. Haemocytometer Calculation and Cell Count Data:
c. Results
i. All 48 wells in EF plate had ES cell growth and therefore all 48
cell lines were harvested and separated into the freeze and growth
batches. The ES cells once grown will then be lysed and the DNA
purified leading to PCR amplification of the target construct
yielding in the identification of the NHEJ and HRE samples.
ii. The 24 well plates do not contain EF layers as that the cells will be
lysed and then analyzed so the desired outcome if rapid growth and
replication in ES media.
c. Results:
i. The goal of the DNA purification was to purify the DNA sample to
be amplified by PCR but first the presence of DNA was observed
via agarose gel electrophoresis.
ii. Gel Picture: DNA presence